Article info
PDFResearch ethics
Paper
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
- Correspondence to Dr Gail E Henderson, Department of Social Medicine, Center for Genomics and Society, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7240, USA; gail_henderson{at}med.unc.edu
Citation
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
Publication history
- Received June 13, 2017
- Revised September 22, 2017
- Accepted October 6, 2017
- First published November 10, 2017.
Online issue publication
March 22, 2018
Article Versions
- Previous version (10 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Other content recommended for you
- When to start paediatric testing of the adult HIV cure research agenda?
- Reconceptualising risk–benefit analyses: the case of HIV cure research
- Cure research and consent: the Mississippi Baby, Barney Clark, Baby Fae and Martin Delaney
- For love and money: the need to rethink benefits in HIV cure studies
- An investigation of patients’ motivations for their participation in genetics-related research
- Addressing ethical challenges in HIV prevention research with people who inject drugs
- Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment
- First-in-human HIV-remission studies: reducing and justifying risk
- Conducting an ongoing HIV clinical trial during the COVID-19 pandemic in Uganda: a qualitative study of research team and participants’ experiences and lessons learnt
- High burden of STIs among HIV-infected adults prior to initiation of ART in South Africa: a retrospective cohort study